drugset / Trial / NCT01307930
Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations
Phase 4
Completed
20 enrolled
Texas Tech University Health Sciences Center
National Center for Research Resources (NCRR) · collabUniversity of Texas Southwestern Medical Center · collab
NaSingle-groupOpen-labelOther
Summary
This study will find how weight affects the dosing of a drug called anidulafungin. Currently, the amount of anidulafungin a patient receives is the same regardless of the patient's weight. BMI groups were for enrollment purposes only and not used for ordinal data analysis.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anidulafungin | Other / unclassified | 100 mg | Intravenous |